Company

CHO Pharma, Inc.

Headquarters: Taipei City, Taiwan

Employees: 35

TWSE: 6586 -3.97%

Market Cap

TW$14.66 Billion

TWD as of July 1, 2024

US$450.3 Million

Market Cap History

CHO Pharma, Inc. market capitalization over time

Evolution of CHO Pharma, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of CHO Pharma, Inc.

Detailed Description

CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04 for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V07 glycan-based vaccines and drugs. The company was founded in 2013 and is based in Taipei City, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

CHO Pharma, Inc. has the following listings and related stock indices.


Stock: TWSE: 6586 wb_incandescent

Details

Headquarters:

Building C

7th Floor No. 99, Lane 130, Section 1 Research Road, Nangang District

Taipei City, 11503

Taiwan

Phone: 886 2 2655 8059

Fax: 886 2 2655 8069